BCM
CELG

BBT Capital Management’s Celgene Corp CELG Stock Holding History

BBT Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-29,566
Closed -$2.8M – 297
2014
Q3 		$2.8M Buy
+29,566
New +$2.67M 0.15% 145

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BBT Capital Management's CELG Position: Q4 2014 in Review

BBT Capital Management sold out of Celgene Corp (CELG) in Q4 2014, closing a stake of 29,566 shares — an estimated $2.8M sold.

BBT Capital Management first reported a position in CELG in Q3 2014 and held it in 1 quarter. The position peaked at $2.8M in Q3 2014. 1,161 funds tracked by Wall St. Rank hold CELG as of Q4 2014.

  • BBT Capital Management reported no remaining Celgene Corp position as of Q4 2014 after selling out during the quarter.
  • BBT Capital Management sold 29,566 Celgene Corp shares in Q4 2014, an estimated $2.8M.
  • BBT Capital Management first reported a position in Celgene Corp in Q3 2014 and held it in 1 quarter.
  • BBT Capital Management's Celgene Corp position peaked at $2.8M in Q3 2014.
  • 1,161 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2014.

Based on BBT Capital Management's 13F filing for Q4 2014, filed 10 Feb 2015.